OOIR: Observatory of International Research

Papers

(The TQCC of Addiction Science & Clinical Practice is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)	72
Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial	51
Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment	43
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder	34
Rethinking trazodone for insomnia in alcohol use disorder	34
Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum—20 years of research informing practice	32
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	31
Comparison of heroin and fentanyl use in US nationally representative surveys	28
Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary	26
Effects of morbidity on smoking cessation: a national smoking cessation program	25
Do in-person and computer-based brief alcohol interventions reduce tobacco smoking among general hospital patients? Secondary outcomes from a randomized controlled trial	24
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou	22
Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial	20
Correction: Do in-person and computer-based brief alcohol interventions reduce tobacco smoking among general hospital patients? Secondary outcomes from a randomized controlled trial	19
Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims	19
A 13-item Health of the Nation Outcome Scale (HoNOS-13): validation by item response theory (IRT) in patients with substance use disorder	19
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review	18
Patient and provider perspectives on self-administered electronic substance use and mental health screening in HIV primary care	17
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis	16
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018	16
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs	15
A mobile-based pregaming drinking prevention intervention for college students: study protocol for a randomized controlled trial	15
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment	15
Augmenting project ECHO for opioid use disorder with data-informed quality improvement	14
The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial	14

‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians	14
Universal substance use care for adolescents with chronic medical conditions: a protocol to examine equitable implementation determinants and strategies for SBIRT at a pediatric hospital	14
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County	13
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d	13
Reimagining brief interventions for alcohol: towards a paradigm fit for the twenty first century?	13
Grayken lessons: between a rock and a hard place? A 37-year-old man with acute liver injury while enrolled in a managed alcohol program for severe alcohol use disorder	13
Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study	13
Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative study	13
Efficacy of mindfulness and goal setting interventions for increasing resilience and reducing smoking in lower socio-economic groups: randomised controlled trial protocol	13
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda	13
Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems	12
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series	12
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	12
Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study	12
How emergency departments are responding to the opioid crisis: Results from a statewide survey in Kentucky	11
Internet-delivered therapy for alcohol misuse: engagement, satisfaction, and outcomes when patients select their preference for therapist- or self-guided treatment	11
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals	10
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England	10
Correction to: A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program	10
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use	10
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes	10
Normalizing fentanyl: interpreting the perceived ‘risk’ of correctional officer work	9
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods	9
Exploring barriers and facilitators to addressing hazardous alcohol use and AUD in mental health services: a qualitative study among Dutch professionals	9
Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey	9
The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic	9
Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial	8
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis	8
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study	8
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting	8
Psychometric assessment of the Moroccan version of the car, relax, alone, forget, friends, trouble (CRAFFT) scale among adolescent and young adults with a substance use disorder	8
A phone-based tobacco use cessation program for people living with HIV in Uganda and Zambia: study protocol for a randomized controlled trial	8
Impact of the COVID-19 pandemic on burnout and perceived workplace quality among addiction treatment providers	8
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky	8
Expanding access to addictions care: Implementation of a 24-hour healthcare provider support line in British Columbia, Canada	8
A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program	7
Formal mindfulness practice predicts reductions in PTSD symptom severity following a mindfulness-based intervention for women with co-occurring PTSD and substance use disorder	6
Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration	6
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites	6
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services	6
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study	6
Feasibility and acceptability of incorporating social network visualizations into a culturally centered motivational network intervention to prevent substance use among urban Native American emerging	6
Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics): A cluster-randomized type 3 hybrid effectiveness-implementation trial	6
Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities	6
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people	6
Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report	6
Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help?	6
Feasibility of a computer-assisted social network motivational interviewing intervention to reduce substance use and increase supportive connections among emerging adults transitioning from homelessne	6
The effects of neighborhood perceptions on response to a technology-assisted parenting intervention for adolescent substance use: protocol of a diversity supplement to parent SMART (Substance Misuse i	6
Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study	6

Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community	5
Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder	5
Proceedings of the 17th Annual International INEBRIA Conference	5
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process	5
What do clinicians want? Understanding frontline addiction treatment clinicians’ preferences and priorities to improve the design of measurement-based care technology	5
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access	5
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	5
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting	5
Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy	5
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial	5
Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study	5
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	5
Attitudes and training related to substance use in pediatric emergency departments	5
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care	5
Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges	5
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy	5
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec	5
Individual differences in treatment effects of internet-based cognitive behavioral therapy in primary care: a moderation analysis of a randomized clinical trial	5
Therapeutic community-oriented day treatment program for Korean women with alcohol use disorder: a non-randomized pilot feasibility trial	5
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	5
Alignment of substance use community benefit prioritization and service lines in US hospitals: a cross-sectional study	5
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis	5
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design	5
Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs	5
“At least someone thinks I’m doing well”: a real-world evaluation of the quit-smoking app StopCoach for lower socio-economic status smokers	5
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology	5